Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > "Trojan Horse" Delivers Drug-Loaded Nanoparticles Deep Into Tumors

Abstract:
One of the most difficult feats to accomplish with today's anticancer therapies is getting drug into the oxygen- and nutrient-deprived cores of solid tumors. These inaccessible regions may be the source of drug-resistant tumors that can recur years after a patient has completed therapy. One type of cell, however, seems to be able to penetrate the tumor mass, and in fact, these cells, known as macrophages, can account for up to 70 percent of the tumor mass in malignancies such as breast cancer. Unfortunately, these tumor-associated macrophages (TAMs) promote rather than impede tumor progression and foster metastasis.

"Trojan Horse" Delivers Drug-Loaded Nanoparticles Deep Into Tumors

Bethesda , MD | Posted on December 5th, 2007

In a case of turning the tables on these TAMs, a team of investigators led by Susan Clare, M.D., Ph.D., has developed methods for loading gold nanoshells into precursor cells known as monocytes, which turn into macrophages in the tumor environment. The monocytes, in essence, become nanoparticle-loaded Trojan horses. Once inside the tumor core, the gold nanoshells can be activated using near-infrared light, turning them into miniature thermal scalpels that kill tumors from the inside out. The investigators have successfully demonstrated each of these steps in an in vitro tumor spheroid model of breast cancer. The results of these studies appear in the journal Nano Letters.

In the first phase of their investigations, the researchers demonstrated that both monocytes and macrophages internalize large numbers of gold nanoshells without suffering any harmful effects. Next, Clare and her colleagues determined that between 10 and 30 seconds of irradiation with a near-infrared laser produced maximal cell death following nanoshell uptake.

Finally, the researchers tested their Trojan horse on breast cancer tumor spheroids. In this experiment, the spheroids were dosed with a mixture of macrophages and nanoshells for 3 days. In controlled experiments, the researchers added only macrophages to the spheroids. Irradiation of both experimental and control spheroids showed conclusively that those spheroids treated with macrophages and gold nanoshells were annihilated when exposed to near-infrared laser irradiation. The spheroids in the control group showed no ill effects.

This work is detailed in the paper "A cellular Trojan horse for delivery of therapeutic nanoparticles into tumors." Investigators at Rice University and Purdue University also participated in this study. This paper was published online in advance of print publication. An abstract of this paper is available through PubMed.

####

About National Cancer Institute
To help meet the goal of reducing the burden of cancer, the National Cancer Institute (NCI), part of the National Institutes of Health, is engaged in efforts to harness the power of nanotechnology to radically change the way we diagnose, treat and prevent cancer.

The NCI Alliance for Nanotechnology in Cancer is a comprehensive, systematized initiative encompassing the public and private sectors, designed to accelerate the application of the best capabilities of nanotechnology to cancer.

Currently, scientists are limited in their ability to turn promising molecular discoveries into benefits for cancer patients. Nanotechnology can provide the technical power and tools that will enable those developing new diagnostics, therapeutics, and preventives to keep pace with today’s explosion in knowledge.

For more information, please click here

Contacts:
National Cancer Institute
Office of Technology & Industrial Relations
ATTN: NCI Alliance for Nanotechnology in Cancer
Building 31, Room 10A49
31 Center Drive , MSC 2580
Bethesda , MD 20892-2580

Copyright © National Cancer Institute

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related Links

View abstract

Related News Press

Nanomedicine

Researchers create vaccine for dust-mite allergies Main Page Content: Vaccine reduced lung inflammation to allergens in lab and animal tests July 22nd, 2014

NIST shows ultrasonically propelled nanorods spin dizzyingly fast July 22nd, 2014

SentiMag® Now Available in Australia and New Zealand July 21st, 2014

More than glitter: Scientists explain how gold nanoparticles easily penetrate cells, making them useful for delivering drugs July 21st, 2014

Discoveries

Iranian Scientists Produce Transparent Nanocomposite Coatings with Longer Lifetime July 24th, 2014

UCF Nanotech Spinout Developing Revolutionary Battery Technology: Power the Next Generation of Electronics with Carbon July 23rd, 2014

A Crystal Wedding in the Nanocosmos July 23rd, 2014

Nano-sized Chip "Sniffs Out" Explosives Far Better than Trained Dogs: TAU researcher's groundbreaking sensor detects miniscule concentrations of hazardous materials in the air July 23rd, 2014

Announcements

Silicene Labs Announces the Launch of Patent-Pending, 2D Materials Composite Index™ : The Initial 2D Materials Composite Index™ for Q2 2014 Is: 857.3; Founders Include World-Renowned Physicist and Seasoned Business and IP Professionals July 24th, 2014

Iranian Scientists Produce Transparent Nanocomposite Coatings with Longer Lifetime July 24th, 2014

Deadline Announced for Registration in 7th Int'l Nanotechnology Festival in Iran July 23rd, 2014

A Crystal Wedding in the Nanocosmos July 23rd, 2014

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE